267 related articles for article (PubMed ID: 17267748)
1. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
Schumacher VA; Jeruschke S; Eitner F; Becker JU; Pitschke G; Ince Y; Miner JH; Leuschner I; Engers R; Everding AS; Bulla M; Royer-Pokora B
J Am Soc Nephrol; 2007 Mar; 18(3):719-29. PubMed ID: 17267748
[TBL] [Abstract][Full Text] [Related]
2. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
3. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
[TBL] [Abstract][Full Text] [Related]
4. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
5. Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome.
Dahan K; Kamal M; Noël LH; Jeanpierre C; Gubler MC; Brousse N; Mariaud de Serre NP
Am J Kidney Dis; 2007 Jun; 49(6):793-800. PubMed ID: 17533022
[TBL] [Abstract][Full Text] [Related]
6. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children.
Yue Z; Pei Y; Sun L; Huang W; Huang H; Hu B; Yang J; Jiang X; Mo Y; Chen S; Lai KN; Wang Y
Ren Fail; 2011; 33(9):910-4. PubMed ID: 21851196
[TBL] [Abstract][Full Text] [Related]
7. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1.
Viney RL; Morrison AA; van den Heuvel LP; Ni L; Mathieson PW; Saleem MA; Ladomery MR
Proteomics; 2007 Mar; 7(5):804-15. PubMed ID: 17295355
[TBL] [Abstract][Full Text] [Related]
8. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
9. The dysregulated glomerular cell growth in Denys-Drash syndrome.
Yang AH; Chen JY; Chen BF
Virchows Arch; 2004 Sep; 445(3):305-14. PubMed ID: 15232745
[TBL] [Abstract][Full Text] [Related]
10. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
11. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
[TBL] [Abstract][Full Text] [Related]
12. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
[TBL] [Abstract][Full Text] [Related]
13. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein.
Cui TG; Foster RR; Saleem M; Mathieson PW; Gillatt DA; Bates DO; Harper SJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F767-73. PubMed ID: 14644752
[TBL] [Abstract][Full Text] [Related]
14. Embryonal hyperplasia of Bowman's capsular epithelium in patients with WT1 mutations.
Fukuzawa R; Eccles MR; Ikeda M; Hata J
Pediatr Nephrol; 2003 Jan; 18(1):9-13. PubMed ID: 12488983
[TBL] [Abstract][Full Text] [Related]
15. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
16. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
17. Glomerular epithelial cell phenotype in diffuse mesangial sclerosis: a report of 2 cases with markedly increased urinary podocyte excretion.
Ikezumi Y; Suzuki T; Karasawa T; Kaneko U; Yamada T; Hasegawa H; Nagata M; Saitoh A
Hum Pathol; 2014 Aug; 45(8):1778-83. PubMed ID: 24856573
[TBL] [Abstract][Full Text] [Related]
18. Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
Swiatecka-Urban A; Mokrzycki MH; Kaskel F; Da Silva F; Denamur E
Pediatr Nephrol; 2001 Aug; 16(8):627-30. PubMed ID: 11519891
[TBL] [Abstract][Full Text] [Related]
19. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
[TBL] [Abstract][Full Text] [Related]
20. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
